244 related articles for article (PubMed ID: 11483267)
1. The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep.
Drew DR; Boyle JS; Lew AM; Lightowlers MW; Chaplin PJ; Strugnell RA
Vaccine; 2001 Aug; 19(31):4417-28. PubMed ID: 11483267
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the Tania ovis 45W antigen.
Drew DR; Lightowlers M; Strugnell RA
Vaccine; 2000 May; 18(23):2522-32. PubMed ID: 10775786
[TBL] [Abstract][Full Text] [Related]
3. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction.
Boyle JS; Brady JL; Lew AM
Nature; 1998 Mar; 392(6674):408-11. PubMed ID: 9537327
[TBL] [Abstract][Full Text] [Related]
4. Site-directed immune responses in DNA vaccines encoding ligand-antigen fusions.
Lew AM; Brady BJ; Boyle BJ
Vaccine; 2000 Feb; 18(16):1681-5. PubMed ID: 10689148
[TBL] [Abstract][Full Text] [Related]
5. Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep.
Chaplin PJ; De Rose R; Boyle JS; McWaters P; Kelly J; Tennent JM; Lew AM; Scheerlinck JP
Infect Immun; 1999 Dec; 67(12):6434-8. PubMed ID: 10569760
[TBL] [Abstract][Full Text] [Related]
6. A comparison of DNA vaccines expressing the 45W, 18k and 16k host-protective antigens of Taenia ovis in mice and sheep.
Drew DR; Lightowlers MW; Strugnell RA
Vet Immunol Immunopathol; 2000 Oct; 76(3-4):171-81. PubMed ID: 11044551
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy.
Kennedy NJ; Spithill TW; Tennent J; Wood PR; Piedrafita D
Vaccine; 2006 Feb; 24(7):970-9. PubMed ID: 16242220
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with plasmid DNA expressing antigen from genomic or cDNA gene forms induces equivalent humoral immune responses.
Drew DR; Lightowlers M; Strugnell RA
Vaccine; 1999 Nov; 18(7-8):692-702. PubMed ID: 10547429
[TBL] [Abstract][Full Text] [Related]
9. Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep.
Rothel JS; Boyle DB; Both GW; Pye AD; Waterkeyn JG; Wood PR; Lightowlers MW
Parasite Immunol; 1997 May; 19(5):221-7. PubMed ID: 9194099
[TBL] [Abstract][Full Text] [Related]
10. Site-directed immunogenesis.
Langermann S
Nat Med; 1998 May; 4(5):547-8. PubMed ID: 9585219
[No Abstract] [Full Text] [Related]
11. Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks.
Lu M; Isogawa M; Xu Y; Hilken G
J Virol; 2005 May; 79(10):6368-76. PubMed ID: 15858020
[TBL] [Abstract][Full Text] [Related]
12. Nucleic acid vaccination of sheep: Use in combination with a conventional adjuvanted vaccine against Taenia ovis.
Rothel JS; Waterkeyn JG; Strugnell RA; Wood PR; Seow HF; Vadolas J; Lightowlers MW
Immunol Cell Biol; 1997 Feb; 75(1):41-6. PubMed ID: 9046433
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of gp120-specific immune responses by genetic vaccination with the human immunodeficiency virus type 1 envelope gene fused to the gene coding for soluble CTLA4.
Nayak BP; Sailaja G; Jabbar AM
J Virol; 2003 Oct; 77(20):10850-61. PubMed ID: 14512535
[TBL] [Abstract][Full Text] [Related]
14. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge.
Deliyannis G; Boyle JS; Brady JL; Brown LE; Lew AM
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6676-80. PubMed ID: 10823919
[TBL] [Abstract][Full Text] [Related]
15. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand.
Prud'homme GJ; Chang Y; Li X
Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of the ErbB2/HER2 tumor antigen to professional APCs results in effective antitumor immunity.
Rohrbach F; Weth R; Kursar M; Sloots A; Mittrücker HW; Wels WS
J Immunol; 2005 May; 174(9):5481-9. PubMed ID: 15843546
[TBL] [Abstract][Full Text] [Related]
17. Immune responses associated with protection in sheep vaccinated with a recombinant antigen from Taenia ovis.
Rothel JS; Lightowlers MW; Seow HF; Wood PR; Rothel LJ; Heath DD; Harrison GB
Parasite Immunol; 1996 Apr; 18(4):201-8. PubMed ID: 9223175
[TBL] [Abstract][Full Text] [Related]
18. The human IgG3 hinge mediates the formation of antigen dimers that enhance humoral immune responses to DNA immunisation.
Drew DR; Boyle JS; Lew AM; Lightowlers MW; Strugnell RA
Vaccine; 2001 Jul; 19(30):4115-20. PubMed ID: 11457535
[TBL] [Abstract][Full Text] [Related]
19. A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.
Chakrabarti R; Zhou ZF; Chang Y; Prud'homme GJ
Vaccine; 2005 Aug; 23(37):4553-64. PubMed ID: 15919138
[TBL] [Abstract][Full Text] [Related]
20. Stimulatory effects of B7-related protein-1 on cellular and humoral immune responses in mice.
Guo J; Stolina M; Bready JV; Yin S; Horan T; Yoshinaga SK; Senaldi G
J Immunol; 2001 May; 166(9):5578-84. PubMed ID: 11313397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
